Your browser doesn't support javascript.
loading
Large-scale structural network change correlates with clinical response to rTMS in depression.
Nestor, Sean M; Mir-Moghtadaei, Arsalan; Vila-Rodriguez, Fidel; Giacobbe, Peter; Daskalakis, Zafiris J; Blumberger, Daniel M; Downar, Jonathan.
Afiliación
  • Nestor SM; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mir-Moghtadaei A; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Vila-Rodriguez F; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Giacobbe P; Krembil Research Institute and Centre for Mental Health, University Health Network, Toronto, ON, Canada.
  • Daskalakis ZJ; Department of Psychiatry, Non-Invasive Neurostimulation Therapies Laboratory, Institute of Mental Health, The University of British Columbia, Vancouver, BC, Canada.
  • Blumberger DM; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Downar J; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Neuropsychopharmacology ; 47(5): 1096-1105, 2022 04.
Article en En | MEDLINE | ID: mdl-35110687
Response to repetitive transcranial magnetic stimulation (rTMS) among individuals with major depressive disorder (MDD) varies widely. The neural mechanisms underlying rTMS are thought to involve changes in large-scale networks. Whether structural network integrity and plasticity are associated with response to rTMS therapy is unclear. Structural MRIs were acquired from a series of 70 adult healthy controls and 268 persons with MDD who participated in two arms of a large randomized, non-inferiority trial, THREE-D, comparing intermittent theta-burst stimulation to high-frequency rTMS of the left dorsolateral prefrontal cortex (DLPFC). Patients were grouped according to percentage improvement on the 17-item Hamilton Depression Rating Score at treatment completion. For the entire sample and then for each treatment arm, multivariate analyses were used to characterize structural covariance networks (SCN) from cortical gray matter thickness, volume, and surface area maps from T1-weighted MRI. The association between SCNs and clinical improvement was assessed. For both study arms, cortical thickness and volume SCNs distinguished healthy controls from MDD (p = 0.005); however, post-hoc analyses did not reveal a significant association between pre-treatment SCN expression and clinical improvement. We also isolated an anticorrelated SCN between the left DLPFC rTMS target site and the subgenual anterior cingulate cortex across cortical measures (p = 0.0004). Post-treatment change in cortical thickness SCN architecture was associated with clinical improvement in treatment responders (p = 0.001), but not in non-responders. Structural network changes may underpin clinical response to rTMS, and SCNs are useful for understanding the pathophysiology of depression and neural mechanisms of plasticity and response to circuit-based treatments.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Trastorno Depresivo Resistente al Tratamiento Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Trastorno Depresivo Resistente al Tratamiento Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Neuropsychopharmacology Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Canadá
...